Product Information
HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE is a generic product labeled by Fresenius Kabi USA, LLC, priced at $5.8995 per ML under NDC 63323011805. Its NADAC has been published 87 times since Nov 20, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
5000 [USP'U]/.5mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323011805
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
5/20/2026
Active Ingredients
HEPARIN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA017029FDA Approved
Before 1982
TE Code
AP
On Market Since
11/16/2018
Pharmacological Classes
Price Statistics
The NADAC for HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE has been published 87 times since Nov 20, 2024, and over the history we have for it it has risen 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.8995 per ML |
|---|---|
| All-time high | $6.6478 (Mar 11, 2026) |
| All-time low | $5.4687 (Nov 20, 2024) |
| 52-week high | $6.6478 |
| 52-week low | $5.8995 |
| Median price | $5.8995 |
| Average price | $5.9270 |
| Largest weekly change | +19.6% (Oct 22, 2025) |
| Weeks tracked | 87 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 80% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Heparin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-coagulant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE, manufactured by Fresenius Kabi USA, LLC, is $5.8995 per ML (NDC 63323011805), effective Sep 30, 2026.
How has the price of HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE has risen 7.9%. It has been tracked across 87 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE?
Since Nov 20, 2024, the NADAC for HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE has ranged from a low of $5.4687 (Nov 20, 2024) to a high of $6.6478 (Mar 11, 2026), with a median of $5.8995 per ML.
Are there cheaper alternatives to HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HEPARIN SODIUM 5,000 UNIT/ML VIAL, is $1.1796 per ML — about 80% below HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE.
Who manufactures HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE?
HEPARIN SODIUM 5,000 UNIT/0.5 ML SYRINGE (NDC 63323011805) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.